Peptide library / Brain & sleep / Noopept
Noopept
A dipeptide-like compound developed in Russia and sold as a memory aid.
Effects studied or claimed
What it is used or promoted for, and where each effect has actually been seen
- Mild cognitive impairmentSmall human studies
- Memory, promotedSmall human studies
How it is thought to work
Noopept is reported to raise NGF and BDNF in the brain and to modulate glutamate receptors, but human mechanisms are not well established.
What the evidence shows
A few small Russian studies reported modest improvements. Large, independent, blinded trials have not been published.
Safety and unknowns
Generally mild effects such as irritability and headache have been reported.
Regulatory status
Approved in Russia. Not FDA-approved, and sold as a supplement elsewhere.
Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.
More in Brain & sleep
P21
Wellness and performanceA small peptide based on ciliary neurotrophic factor, studied in mice for memory and neurogenesis.
PE-22-28
Wellness and performanceA short synthetic peptide studied in mice as a fast-acting antidepressant.
NNZ-2591
In clinical trialsAn investigational synthetic analog of a natural brain peptide, in development for rare neurodevelopmental disorders.
General information, not medical advice. Do not buy or inject unregulated peptides.